| Year |
Citation |
Score |
| 2015 |
Wang ZJ, Wan ZN, Chen XD, Wu CF, Gao GL, Liu R, Shi Z, Bao JK. In silico identification of novel kinase inhibitors by targeting B-Raf(v660e) from natural products database. Journal of Molecular Modeling. 21: 102. PMID 25832798 DOI: 10.1007/s00894-015-2647-8 |
0.303 |
|
| 2015 |
Ma LY, Zheng YC, Wang SQ, Wang B, Wang ZR, Pang LP, Zhang M, Wang JW, Ding L, Li J, Wang C, Hu B, Liu Y, Zhang XD, Wang JJ, ... Wang ZJ, et al. Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents. Journal of Medicinal Chemistry. 58: 1705-16. PMID 25610955 DOI: 10.1021/acs.jmedchem.5b00037 |
0.342 |
|
| 2013 |
Ochiana SO, Pandarinath V, Wang Z, Kapoor R, Ondrechen MJ, Ruben L, Pollastri MP. The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing. European Journal of Medicinal Chemistry. 62: 777-84. PMID 22889561 DOI: 10.1016/J.Ejmech.2012.07.038 |
0.611 |
|
| 2011 |
Bland ND, Wang C, Tallman C, Gustafson AE, Wang Z, Ashton TD, Ochiana SO, McAllister G, Cotter K, Fang AP, Gechijian L, Garceau N, Gangurde R, Ortenberg R, Ondrechen MJ, et al. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness. Journal of Medicinal Chemistry. 54: 8188-94. PMID 22023548 DOI: 10.1021/Jm201148S |
0.517 |
|
| 2009 |
Grunwald J, Rejtar T, Sawant R, Wang Z, Torchilin VP. TAT peptide and its conjugates: proteolytic stability. Bioconjugate Chemistry. 20: 1531-7. PMID 19601640 DOI: 10.1021/Bc900081E |
0.315 |
|
| Show low-probability matches. |